About this trial
Mechanical power (MP) is a composite variable that integrates static and dynamic respiratory parameters and has been associated with ventilator-induced lung injury (VILI). MP is predominantly delivered to the reduced functional lung size, commonly referred to as the "baby lung" (BL). Functional lung size, in turn, is closely related to respiratory system compliance (Crs). Previous studies have demonstrated an association between MP normalized to compliance (MP/Crs) and mortality. Moreover, evidence suggests that VILI associated with MP/Crs results primarily from the combined effect of its components rather than from any single component in isolation.
The objective of this study is to evaluate both the overall and the relative contribution of each component of mechanical power, normalized to compliance (MP/Crs), to in-hospital mortality in patients with acute respiratory distress syndrome (ARDS).
Eligibility criteria
Qualifiers
Patients ≥ 18 years
Diagnosis of acute respiratory distress syndrome
Receiving invasive mechanical ventilation (volume control mode) for at least 48 consecutive hours.
Disqualifiers
Patients spontaneously breathing
Patients under non-invasive support therapies
Patients receiving ventilation through a tracheostomy cannula at any time during the first 48 h
Patients that receiving pressure-controlled ventilation or any modality other than volume-controlled
Trial design
Treatments tested in this trial
- monitoring of clinical and ventilatory variables
Treatment groups
Locations
Sponsors and collaborators
Ramos Mejía Hospital
Lead sponsor
Universidad de la Republica
Collaborator